SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shyamal H. Mehta, John C. Morgan, Kapil D. Sethi, Drug-induced Movement Disorders, Neurologic Clinics, 2015, 33, 1, 153

    CrossRef

  2. 2
    Rebakah Sumalini Abel Boenerjous, William Zirker, Suhas Masilamani, Elderly Nursing Home Resident With Head Drop, Journal of the American Medical Directors Association, 2015,

    CrossRef

  3. 3
    Leslie J. Cloud, Deepti Zutshi, Stewart A. Factor, Tardive Dyskinesia: Therapeutic Options for an Increasingly Common Disorder, Neurotherapeutics, 2014, 11, 1, 166

    CrossRef

  4. 4
    Maria Stamelou, Scarlett C. Lai, Annu Aggarwal, Susanne A. Schneider, Henry Houlden, Tu-Hsueh Yeh, Amit Batla, Chin-Song Lu, Mohit Bhatt, Kailash P. Bhatia, Dystonic opisthotonus: A “red flag” for neurodegeneration with brain iron accumulation syndromes?, Movement Disorders, 2013, 28, 10
  5. 5
    Travis S. Tierney, Andres M. Lozano, Surgical treatment for secondary dystonia, Movement Disorders, 2012, 27, 13
  6. 6
    Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience 3E, 2012,

    CrossRef

  7. 7
    Terence D. Sanger, Johnathon W. Mink, Swaiman's Pediatric Neurology, 2012,

    CrossRef

  8. 8
    Manuchair Ebadi, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  9. 9
    Roongroj Bhidayasiri, Kathrin Czarnecki, Daniel Tarsy, Handbook of Dystonia, 2012,

    CrossRef

  10. 10
    Francisco Cardoso, Handbook of Dystonia, 2012,

    CrossRef

  11. 11
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  12. 12
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  13. 13
    Dirk Dressler, Hyperkinetic Movement Disorders, 2011,

    CrossRef

  14. 14
    Marian L. Evatt, Alan Freeman, Stewart Factor, Hyperkinetic Movement Disorders, 2011,

    CrossRef

  15. 15
    Ainhi D. Ha, Joseph Jankovic, Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia, 2011,

    CrossRef

  16. 16
    David R.P. Guay, Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders, The American Journal of Geriatric Pharmacotherapy, 2010, 8, 4, 331

    CrossRef

  17. 17
    A. Rajput, Encyclopedia of Movement Disorders, 2010,

    CrossRef

  18. 18
    R. Wolf Gilbert, C. Waters, Encyclopedia of Movement Disorders, 2010,

    CrossRef

  19. 19
    P. Greene, Encyclopedia of Movement Disorders, 2010,

    CrossRef

  20. 20
    Yasar Kutukçu, Semai Bek, Tayfun Kasikçi, Gençer Genç, Zeki Odabasi, Eating dystonia, Movement Disorders, 2009, 24, 15
  21. 21
    Clecio Godeiro-Junior, Andre C. Felício, Patrícia de Carvalho Aguiar, Vanderci Borges, Sonia M. A. Silva, Henrique B. Ferraz, Neuroleptic-Induced Tardive Cervical Dystonia: Clinical Series of 20 Patients, The Canadian Journal of Neurological Sciences, 2009, 36, 02, 222

    CrossRef

  22. 22
    Bernardo de Mattos Viana, Hugo Alejandro Cano Prais, Sarah Teixeira Camargos, Francisco Eduardo Costa Cardoso, Ziprasidone-related oculogyric crisis in an adult, Clinical Neurology and Neurosurgery, 2009, 111, 10, 883

    CrossRef

  23. 23
    Spiridon Papapetropoulos, Sheila Baez, Jennifer Zitser, Cenk Sengun, Carlos Singer, Retrocollis: Classification, Clinical Phenotype, Treatment Outcomes and Risk Factors, European Neurology, 2008, 59, 1-2, 71

    CrossRef

  24. 24
    Levent Sevincok, Volkan Balci, Utku Akyildiz, Tardive Dystonia Associated With Low-Dose of Amisulpride, Journal of Clinical Psychopharmacology, 2008, 28, 5, 573

    CrossRef

  25. 25
    Hyun-Kook Lim, Chi-Un Pae, Chul Lee, Chang-Uk Lee, Tardive dystonic symptoms associated with aripiprazole treatment, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2008, 32, 2, 589

    CrossRef

  26. 26
    MARY V SEEMAN, DAVID CLODMAN, GARY REMINGTON, Transient Tardive Dystonia: Overview and Case Presentation, Journal of Psychiatric Practice, 2008, 14, 4, 251

    CrossRef

  27. 27
    Textbook of Clinical Neuropsychiatry Second edition, 2008,

    CrossRef

  28. 28
    Mark B. Detweiler, Naciye Kalafat, Kye Y. Kim, Drug-Induced Movement Disorders in Older Adults: An Overview for Clinical Practitioners, The Consultant Pharmacist, 2007, 22, 2, 149

    CrossRef

  29. 29
    Takefumi Suzuki⁎, Hiroyuki Uchida, Koichiro Watanabe, Haruo Kashima, Treating a schizophrenic patient with severe tardive dystonia without antipsychotics, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2007, 31, 5, 1141

    CrossRef

  30. 30
    Howard L. Geyer, Susan B. Bressman, TREATMENT OF DYSTONIA, CONTINUUM: Lifelong Learning in Neurology, 2007, 13, 94

    CrossRef

  31. 31
    Mark Edwards, Kailash Bhatia, Clinical Diagnosis and Management of Dystonia, 2007,

    CrossRef

  32. 32
    Carlos Singer, Spiridon Papapetropoulos, A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia, Parkinsonism & Related Disorders, 2006, 12, 2, 115

    CrossRef

  33. 33
    Kelvin L. Chou, Joseph H. Friedman, Tardive Syndromes in the Elderly, Clinics in Geriatric Medicine, 2006, 22, 4, 915

    CrossRef

  34. 34
    Roongroj Bhidayasiri, Daniel Tarsy, Treatment of dystonia, Expert Review of Neurotherapeutics, 2006, 6, 6, 863

    CrossRef

  35. 35
    Roongroj Bhidayasiri, Daniel Tarsy, Handbook of Dystonia, 2006,

    CrossRef

  36. 36
    Francisco Cardoso, Handbook of Dystonia, 2006,

    CrossRef

  37. 37
    Angelo Franzini, Carlo Marras, Paolo Ferroli, Giovanna Zorzi, Orso Bugiani, Luigi Romito, Giovanni Broggi, Long-term high-frequency bilateral pallidal stimulation for neuroleptic-induced tardive dystonia, Journal of Neurosurgery, 2005, 102, 4, 721

    CrossRef

  38. 38
    Philippos Gourzis, Panagiotis Polychronopoulos, Spiridon Papapetropoulos, Konstantinos Assimakopoulos, Andreas A Argyriou, Stavroula Beratis, Quetiapine in the Treatment of Focal Tardive Dystonia Induced by Other Atypical Antipsychotics, Clinical Neuropharmacology, 2005, 28, 4, 195

    CrossRef

  39. 39
    Frank Skidmore, Stephen G. Reich, Tardive dystonia, Current Treatment Options in Neurology, 2005, 7, 3, 231

    CrossRef

  40. 40
    Joseph H. Friedman, Hubert H. Fernandez, Animal Models of Movement Disorders, 2005,

    CrossRef

  41. 41
    Drug-Induced Movement Disorders, 2004,

    CrossRef

  42. 42
    Drug-Induced Movement Disorders, 2004,

    CrossRef

  43. 43
    Hubert H. Fernandez, Joseph H. Friedman, CLASSIFICATION AND TREATMENT OF TARDIVE SYNDROMES, The Neurologist, 2003, 9, 1, 16

    CrossRef

  44. 44
    Toshihito Suzuki, Hisashi Matsuzaka, Drug-Induced Pisa Syndrome (Pleurothotonus), CNS Drugs, 2002, 16, 3, 165

    CrossRef

  45. 45
    Claudio Lucetti, Giovanna Bellini, Angelo Nuti, Silvia Bernardini, Grazia Dell'Agnello, Armando Piccinni, Luca Maggi, Laura Manca, Ubaldo Bonuccelli, Treatment of Patients With Tardive Dystonia With Olanzapine, Clinical Neuropharmacology, 2002, 25, 2, 71

    CrossRef

  46. 46
    Michael P. Caligiuri, Dilip V. Jeste, Jonathan P. Lacro, Antipsychotic-Induced Movement Disorders in the Elderly, Drugs & Aging, 2000, 17, 5, 363

    CrossRef

  47. 47
    Keizo Yoshida, Hitoshi Takahashi, Kazuhiro Sato, Hisashi Higuchi, Tetsuo Shimizu, Biperiden hydrochlorate ameliorates dystonia of rats produced by microinjection of sigma ligands into the red nucleus, Pharmacology Biochemistry and Behavior, 2000, 67, 3, 497

    CrossRef

  48. 48
    Daniel Tarsy, Tardive dyskinesia, Current Treatment Options in Neurology, 2000, 2, 3, 205

    CrossRef

  49. 49
    Dominic Thyagarajan, Dystonia: recent advances, Journal of Clinical Neuroscience, 1999, 6, 1, 1

    CrossRef

  50. 50
    Eric S. Molho, Stewart A. Factor, Possible tardive dystonia resulting from clozapine therapy, Movement Disorders, 1999, 14, 5
  51. 51
    Adityanjee, Yekeen A Aderibigbe, V.Chowdary Jampala, Thomas Mathews, The current status of tardive dystonia, Biological Psychiatry, 1999, 45, 6, 715

    CrossRef

  52. 52
    Eric S. Molho, Paul J. Feustel, Stewart A. Factor, Clinical comparison of tardive and idiopathic cervical dystonia, Movement Disorders, 1998, 13, 3
  53. 53
    Iris Maurer, Thomas Grunwald, Christian E. Elger, Clozapine treatment of delayed-onset paroxysmal hemidystonia, Movement Disorders, 1998, 13, 3
  54. 54
    Paul Krack, Sybilla Schneider, Günther Deuschl, Geste device in tardive dystonia with retrocollis and opisthotonic posturing, Movement Disorders, 1998, 13, 1
  55. 55
    Kiyoshi Maeda, Toshiko Ohsaki, Katsutoshi Kuki, kohshu Kin, Manabu Ikeda, Yoshio Matsumoto, Severe antecollis during antipsychotics treatment: A report of three cases, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1998, 22, 5, 749

    CrossRef

  56. 56
    William T Dauer, Stanley Fahn, Robert E Burke, The Diagnosis and Treatment of Tardive Disorders, Medical Update for Psychiatrists, 1998, 3, 4, 119

    CrossRef

  57. 57
    Fred Ovsiew, Kimford J. Meador, Kapil Sethi, Verapamil for severe hyperkinetic movement disorders, Movement Disorders, 1998, 13, 2
  58. 58
    Anjan Chatterjee, Mark Forrest Gordon, Nir Giladi, Richard Trosch, Botulinum Toxin in the Treatment of Tardive Dystonia, Journal of Clinical Psychopharmacology, 1997, 17, 6, 497

    CrossRef

  59. 59
    M. Raja, A. Azzoni, Tardive dystonia, The Italian Journal of Neurological Sciences, 1996, 17, 6, 409

    CrossRef

  60. 60
    Michele Raja, Giovanni Maisto, Maria Concetta Altavista, Alberto Albanese, Tardive lingual dystonia treated with clozapine, Movement Disorders, 1996, 11, 5
  61. 61
    Michele Raja, Tardive Dystonia, European Archives of Psychiatry and Clinical Neuroscience, 1995, 245, 3, 145

    CrossRef

  62. 62
    Joseph H. Friedman, Clozapine treatment of psychosis in patients with tardive dystonia: Report of three cases, Movement Disorders, 1994, 9, 3
  63. 63
    Progress in Psychiatry, New England Journal of Medicine, 1994, 330, 4, 285

    CrossRef

  64. 64
    Joel M. Trugman, Robert Leadbetter, Michael E. Zalis, Rose O. Burgdorf, G. Frederick Wooten, Treatment of severe axial tardive dystonia with clozapine: Case report and hypothesis, Movement Disorders, 1994, 9, 4
  65. 65
    Thomas R.E. Barnes, J. Guy Edwards, Antipsychotic Drugs and their Side-Effects, 1993,

    CrossRef

  66. 66
    Lucinda G. Miller, Joseph Jankovic, Persistent dystonia possibly induced by flecainide, Movement Disorders, 1992, 7, 1
  67. 67
    Celina F. Tolge, Stewart A. Factor, Focal dystonia secondary to cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome, Movement Disorders, 1991, 6, 1
  68. 68
    Doreen E. Robertson-Hoffman, Margery H. Mark, Jacob I. Sage, Isolated lingual/palatal dystonia, Movement Disorders, 1991, 6, 2
  69. 69
    Thomas R. E. Barnes, Movement Disorder Associated with Antipsychotic Drugs: The Tardive Syndromes, International Review of Psychiatry, 1990, 2, 3-4, 355

    CrossRef

  70. 70
    N. Diederich, C. G. Goetz, C. L. Comella, New approaches in the treatment of the dystonias, Klinische Wochenschrift, 1990, 68, 19, 935

    CrossRef

  71. 71
    Kapil D. Sethi, David C. Hess, Rollie J. Harp, Prevalence of dystonia in veterans on chronic antipsychotic therapy, Movement Disorders, 1990, 5, 4
  72. 72
    Lucinda G. Miller, Joseph Jankovic, Sulpiride-induced tardive dystonia, Movement Disorders, 1990, 5, 1
  73. 73
    Stanley Fahn, Robert Burke, Yaakov Stern, Cholinergic Neurotransmission: Functional and Clinical Aspects, 1990,

    CrossRef

  74. 74
    Stanislaw Wolfarth, Krystyna Ossowska, Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia?, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1989, 13, 6, 799

    CrossRef

  75. 75
    David M. Kaufman, Facial Dyskinesias, Psychosomatics, 1989, 30, 3, 263

    CrossRef

  76. 76
    Jeffrey L. Cummings, William C. Wirshing, Recognition and Differential Diagnosis of Tardive Dyskinesia, The International Journal of Psychiatry in Medicine, 1989, 19, 2, 133

    CrossRef

  77. 77
    Robert E. Burke, Un Jung Kang, Joseph Jankovic, Lucinda G. Miller, Stanley Fahn, Tardive akathisia: An analysis of clinical features and response to open therapeutic trials, Movement Disorders, 1989, 4, 2
  78. 78
    Jean Lud Cadet, The iminodipropionitrile (IDPN)-induced dyskinetic syndrome: Behavioral and biochemical pharmacology, Neuroscience & Biobehavioral Reviews, 1989, 13, 1, 39

    CrossRef

  79. 79
    J. L. Cadet, F. Karoum, Central and peripheral effects of iminodipropionitrile on catecholamine metabolism in rats, Synapse, 1988, 2, 1
  80. 80
    Stanley Fahn, Is the thought disorder with oculogyric crisis a feature of tardive akathisia or tardive dysphrenia?, Annals of Neurology, 1988, 23, 3
  81. 81
    Jean Lud Cadet, Taylor Edward, William J. Freed, The iminodipropionitrile (IDPN)-induced dyskinetic syndrome in mice: Antagonism by the calcium channel antagonist nifedipine, Pharmacology Biochemistry and Behavior, 1988, 29, 2, 381

    CrossRef

  82. 82
    John T. Little, Joseph Jankovic, Tardive myoclonusa, Movement Disorders, 1987, 2, 4